跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES
Approved
STANDARD
LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES
Glaxosmithkline Gmbh & Co. Kg
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 20, 2022
Approval ID
344b9b324bfbf610
Company
Glaxosmithkline Gmbh & Co. Kg
Type
Standard
Approval Details
Approval Id
344b9b324bfbf610
Drug Cima Aemps Name
LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number
33122.03.00
Holder Company Name
Glaxosmithkline Gmbh & Co. Kg
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/glaxosmithkline-gmbh-and-co-kg
Authorization Date
2022-01-20
Dosage Form
COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Glaxosmithkline Gmbh & Co. Kg
Company Detail Path
/organization/glaxosmithkline-gmbh-and-co-kg
Company Information
Pharmaceutical Company Name
GlaxoSmithKline GmbH & Co. KG
Country Name
Germany
City Name
hamburg,hamburg,country_de
Address
Heidenkampsweg 51
Active Ingredients
LAMOTRIGINA
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 20, 2022
Approval ID
344b9b324bfbf610
Type
Standard
Back to CIMA-AEMPS Approvals